Change in retinal vein ODF may provide additional information to assist with glaucoma prognostication and implies a significant relationship between venous change and glaucoma patho-physiology.
A total of 16.8% of the eyes observed in this study had either disc haemorrhages or vascular changes. The underlying trend of vascular and haemorrhagic changes in glaucoma are demonstrated in this sample, which is in general agreement with previous studies. The high percentage of optic disc haemorrhages in low tension glaucoma is highlighted. The presence of microaneurysms and nerve fibre layer haemorrhages is interesting but of unknown significance.
An image analyser installed in a 16 bit personal computer was used to measure grey levels in red free photographs of normal and glaucomatous eyes. Regional photographic image intensity and density were correlated with Humphrey Field Analyser results for corresponding areas of visual field. Two methods for standardising photographic exposure by histogram equalisation and slide were compared in two groups of eyes from 13 subjects. For histogram equalisation, r2 varied from 0.16 to 0.29 for linear fits in temporal retinal quadrants. For the histogram slide, r2 varied between 0.19 to 0.45 for linear fits. Similar results were found for mean histogram equalised image intensity versus Humphrey Field Analyser global indices: Mean Deviation, (r2 = 0.27) and Pattern Standard Deviation, (r2 = 0.37). For histogram equalised image data, resistant line analysis showed a linear goodness of fit of 0.92 and for histogram slide goodness of fit was 0.97 for upper and 0.87 for lower temporal quadrants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.